News
News
- Bavarian Nordic Announces a New Order for JYNNEOS Smallpox Vaccine from the U.S. Government Potentially Worth USD 200 Million
04/30/2020 / 18:46 - GlobeNewswire - Bavarian Nordic Announces the Sale of Priority Review Voucher
12/17/2019 / 19:36 - GlobeNewswire - Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda’s Preparedness Against Ebola Outbreak
12/09/2019 / 07:00 - GlobeNewswire - Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine
11/14/2019 / 08:23 - GlobeNewswire - Bavarian Nordic Completes Enrollment of Phase 3 Lot-Consistency Trial of Freeze-dried Smallpox Vaccine
11/11/2019 / 07:30 - GlobeNewswire - Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen
11/07/2019 / 12:03 - GlobeNewswire - Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications
11/06/2019 / 11:33 - GlobeNewswire - Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo
10/31/2019 / 13:24 - GlobeNewswire - Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
10/21/2019 / 08:59 - GlobeNewswire - Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
10/08/2019 / 08:44 - GlobeNewswire
Real-time